Delivery Order SPE2DB20D2001-SPE2DB24FM78Y

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.76 firm fixed price contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product, to support federal healthcare programs. The contract has a performance period through May 12, 2023 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,281.85 firm fixed-price contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 8S medical products, with a completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a Delivery Order contract valued at $1,550.40 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a vaginal medication insert. The contract has an ultimate completion date of July 1, 2022 and uses a Firm Fixed Price pricing type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.08 firm fixed-price contract is for the delivery of YUVAFEM 10 MCG vaginal inserts. The contract has an ultimate completion date of March 29, 2023 and was awarded on March 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of YUVAFEM 10 MCG vaginal inserts. The order, valued at $1,735.40, has a firm fixed price and an ultimate completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a range of medical commodities to support military...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,396.56 firm fixed-price contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S medical products. The contract has an ultimate completion date of January 3, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as a primary vehicle...
This is a $1,145.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,071.10 firm-fixed-price contract is for the supply of 4565322370 - YUVAFEM 10 MCG VAGINAL INSERT 8S, a medical product. The award does not have a set-aside designation and has an ultimate completion date of August 2, 2024. AmerisourceBergen has been awarded multiple Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The award is for $1,688.52 to supply YUVAFEM 10 MCG VAGINAL INSERT 8S, a pharmaceutical product. The contract has a firm fixed-price payment structure and an ultimate completion date of October 15, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds several significant...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S, a prescription pharmaceutical product. The $7,741.95 firm fixed price contract has a completion date of September 25, 2024. As a major pharmaceutical distributor, AmerisourceBergen provides a wide range of medical commodities to support government healthcare programs, including military treatment facilities and veterans' hospitals. The company...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB24FM78Y
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,659.36 firm fixed-price contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a medical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:00 AM